Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice
- PMID: 10321985
- DOI: 10.3109/13550289909022003
Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice
Abstract
Neuropathogenic lactate dehydrogenase-elevating viruses (LDV) cytocidally infect anterior horn neurons in C58 and AKR mice via interaction with endogenous murine retroviruses to cause a paralytic disease, age-dependent poliomyelitis (ADPM). The induction of ADPM requires a suppressed host immune system as a result of old age, genetic defects (such as nude mice) or any immunosuppressive treatment. Previous results have shown that the infection of anterior horn neurons by neuropathogenic LDV isolates and the subsequent development of ADPM are prevented by anti-LDV antibodies either induced actively during infection or when passively administered. However, the mechanism of protection was unclear since both neutralizing and non-neutralizing polyclonal antibodies seemed protective, whereas only neutralizing monoclonal antibodies were protective. Furthermore, the protection of motor neurons from infection occurred in the absence of any apparent effect on LDV replication in a subpopulation of macrophages known to be the primary permissive host cells. These paradoxes have now been resolved. We have recently reported that the neuropathogenic LDV isolates contain both neuropathogenic and non-neuropathogenic quasispecies that differ in their ability to establish a high viremia persistent infection. Using biological clones of both neuropathogenic and non-neuropathogenic quasispecies, we now demonstrate that both replicate in the same subpopulation of permissive macrophages, but that the neuropathogenic quasispecies are about 100 times more susceptible to in vitro antibody neutralization than the non-neuropathogenic ones, and that antibodies that neutralize the neuropathogenic but not the non-neuropathogenic quasispecies develop as soon as 7 days after infection with neuropathogenic LDVs and selectively suppress the replication of the neuropathogenic LDVs in vivo in FVB, BALB/c, C57 BL/6 and C58 mice. The previously observed lack of neutralizing effect of early polyclonal anti-LDV antibodies and the apparent ineffective antibody control of LDV replication in macrophages were due to outgrowth of the non-neuropathogenic quasispecies that are also present in the neuropathogenic LDV inoculum and are highly resistant to antibody neutralization. Using cloned neuropathogenic LDV quasispecies, we demonstrate a clear relationship in the development of neutralizing antibodies, replication suppression of the neuropathogenic LDVs and the prevention of ADPM in C58 mice. Our results therefore establish an inseparable relationship between the neuron-protective effect of an antibody and its neutralization of the neuropathogenic LDV quasispecies and explain why neuropathogenic LDVs cause paralytic disease only in immunosuppressed mice.
Similar articles
-
Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection.J Neurovirol. 1998 Oct;4(5):560-8. doi: 10.3109/13550289809113501. J Neurovirol. 1998. PMID: 9839654
-
Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.J Virol. 1997 Apr;71(4):2913-20. doi: 10.1128/JVI.71.4.2913-2920.1997. J Virol. 1997. PMID: 9060649 Free PMC article.
-
Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.Virus Res. 2003 Mar;92(1):83-7. doi: 10.1016/s0168-1702(02)00321-0. Virus Res. 2003. PMID: 12606079
-
Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution.Arch Virol. 2001 Jul;146(7):1283-96. doi: 10.1007/s007050170091. Arch Virol. 2001. PMID: 11556706
-
Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia.Autoimmun Rev. 2005 Apr;4(4):247-52. doi: 10.1016/j.autrev.2004.11.010. Epub 2004 Dec 14. Autoimmun Rev. 2005. PMID: 15893720 Free PMC article. Review.
Cited by
-
The antiviral activity of antibodies in vitro and in vivo.Adv Immunol. 2001;77:195-262. doi: 10.1016/s0065-2776(01)77018-6. Adv Immunol. 2001. PMID: 11293117 Free PMC article. Review.
-
Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development.Vet Microbiol. 2000 Jun 12;74(4):309-29. doi: 10.1016/s0378-1135(00)00196-6. Vet Microbiol. 2000. PMID: 10831854 Free PMC article. Review.
-
Age-dependent poliomyelitis in mice is associated with respiratory failure and viral replication in the central nervous system and lung.J Neurovirol. 2001 Jun;7(3):265-71. doi: 10.1080/13550280152403308. J Neurovirol. 2001. PMID: 11517400
-
Modified-live PRRSV subtype 1 vaccine UNISTRAIN® PRRS provides a partial clinical and virological protection upon challenge with East European subtype 3 PRRSV strain Lena.Porcine Health Manag. 2016 May 9;2:12. doi: 10.1186/s40813-016-0029-y. eCollection 2016. Porcine Health Manag. 2016. PMID: 28405438 Free PMC article.
-
High genetic diversity and adaptive potential of two simian hemorrhagic fever viruses in a wild primate population.PLoS One. 2014 Mar 20;9(3):e90714. doi: 10.1371/journal.pone.0090714. eCollection 2014. PLoS One. 2014. PMID: 24651479 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical